SCHEMBL514357

SCHEMBL514357

CC(C)C(=O)Oc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.72
ATM Q13315 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
ALDH1A1 P00352 3/20 0.46
GAA P10253 2/20 0.46
LMNA P02545 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 3/20 0.46
HSP90AA1 P07900 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
HPGD P15428 2/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29187166 1.00 ELANE (0.72) ELANEATML3MBTL1ALDH1A1GAA
Hydrochloric Acid SCHEMBL25243908 0.98 ELANE (0.70) ELANEATML3MBTL1ALDH1A1GAA
SCHEMBL30894420 0.98 ELANE (0.70) ELANEATML3MBTL1ALDH1A1GAA
Hydrochloric Acid SCHEMBL27392624 0.96 ELANE (0.68) ELANEATML3MBTL1ALDH1A1GAA
SCHEMBL27702601 0.94 ELANE (0.66) ELANEATML3MBTL1ALDH1A1GAA
Acetaldehyde SCHEMBL21059045 0.92 ELANE (0.64) ELANEATML3MBTL1ALDH1A1GAA
SCHEMBL6032614 0.92 ELANE (0.69) ELANEATML3MBTL1ALDH1A1HPGD
SCHEMBL21795326 0.88 ELANE (0.79) ELANEATML3MBTL1ALDH1A1LMNA
SCHEMBL5317551 0.88 ELANE (0.69) ELANEGAALMNAKMT2AMEN1
SCHEMBL2459478 0.86 ELANE (0.56) ELANEATML3MBTL1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129015-A1 HALOGENATED BENZYLIDINE DERIVATIVES Renovel Innovations, Inc. (US) 2025-04-24 US claimed
CN-112779304-B Preparation method of parallel ring pyridone compound 广东东阳光药业股份有限公司 2023-11-03 CN claimed
US-20230107812-A1 HALOGENATED BENZYLIDINE DERIVATIVES Renovel Innovations, Inc. 2023-04-06 US claimed
CN-111166708-B December perfume and preparation method thereof 华东理工大学 2022-09-16 CN claimed
CN-111135134-B Twenty-four solar terms perfume and preparation method thereof 华东理工大学 2022-09-13 CN claimed
WO-2022050385-A1 PHENOL DERIVATIVE 大日本住友製薬株式会社 2022-03-10 WO claimed
CN-114041459-A Processing liquid for preserving natural primary color of fresh cut camellia and application thereof 云南欣绿茶花股份有限公司 2022-02-15 CN claimed
CN-109553711-B Catalyst component for olefin polymerization and catalyst thereof 中国石油化工股份有限公司 2021-04-13 CN claimed
CN-109553706-B Catalyst component for olefin polymerization, catalyst and application 中国石油化工股份有限公司 2021-04-13 CN claimed
CN-109553703-B Catalyst component for olefin polymerization and preparation method thereof 中国石油化工股份有限公司 2021-04-13 CN claimed
CN-1090935-C Pharmaceutical composition for piperidinoalkanol compounds AVENTIS PHARMA INC (US) 2002-09-18 CN claimed
CN-1309121-A Method for resolving alpha- [ 4- (1, 1-dimethylethyl) phenyl ] -4- (hydroxydiphenylmethyl) -1-piperidinebutanol and compounds derived therefrom MERRELL DOW PHARMA (US) 2001-08-22 CN claimed
WO-2001044151-A1 PREPARATION OF 2-(4-ETHOXYPHENYL)-2-METHYLPROPYL ALCOHOL ISAGRO (ASIA) AGROCHEMICALS PRIVATE LIMITED (IN) 2001-06-21 WO claimed
US-6221894-B1 ACARICIDAL, ANTIPARASITIC, INSECTICIDAL AND ANTHELMINTIC AGENTS. MERCK & CO., INC. 2001-04-24 US claimed
CN-1278728-A Compositions and methods for treating respiratory disorders PROCTER 7 GAMBLE COMPANY (US) 2001-01-03 CN claimed
CN-1268050-A Pharmaceutical composition for combination of piperidinoalkanol-decongestant HOECHST MARION ROUSSEL INC (US) 2000-09-27 CN claimed
CN-1187125-A Oral pharmaceutical composition of piperidinoalkanol compounds in solution form HOECHST MARION ROUSSEL INC (US) 1998-07-08 CN claimed
CN-1176599-A Pharmaceutical composition for piperidinoalkanol compounds HOECHST MARION ROUSSEL INC (US) 1998-03-18 CN claimed
CN-1148382-A Process and diastereomeric salts for optical resolution of racemic alpha- [4- (1, 1-dimethylethyl) phenyl ] -4- (hydroxydiphenylmethyl) -1-piperidinebutanol and compounds derived therefrom MERRELL DOW PHARMA (US) 1997-04-23 CN claimed
US-3987175-A ATHEROSCLEROSIS PIERRE FABRE S.A. (FR) 1976-10-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129015-A1 HALOGENATED BENZYLIDINE DERIVATIVES BRD2, MPO, BRD9 ELANE 253/4885ATM 3784/4885L3MBTL1 524/4885
US-20230107812-A1 HALOGENATED BENZYLIDINE DERIVATIVES BRD2, MPO, BRD9 ELANE 253/4885ATM 3784/4885L3MBTL1 524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.